Centro De Patologia Avanzada De Puerto Rico is categorized under Pathological Laboratories in , and active since 2002.
Centro De Patologia Avanzada De Puerto Rico was established in 2002, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Pathological Laboratories business, which does work in the B2C market, and is classified as a Pathological Laboratories, under code number 621511 by the NAICS.
If you are seeking more information, feel free to contact Delba Garrastegui at the company’s single location by writing to Calle 8 Bloque I 32 Dvlas St Cal, , 00959 or by phoning (787) 995-1818. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Centro De Patologia Avanzada De Puerto Rico |
Contact Person: | Delba Garrastegui |
Address: | Calle 8 Bloque I 32 Dvlas St Cal, , 00959 |
Phone Number: | (787) 995-1818 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2002 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Pathological Laboratories |
SIC Code: | 8071 |
NAICS Code: | 621511 |
Share This Business: |
Centro De Patologia Avanzada De Puerto Rico was started in 2002 to provide professional Pathological Laboratories under the SIC code 8071 and NAICS code 621511. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Delba Garrastegui for inquiries that concern Centro De Patologia Avanzada De Puerto Rico by calling the company number (787) 995-1818, as your correspondence is most welcome. Additionally, the physical location of the single location of Centro De Patologia Avanzada De Puerto Rico can be found at the coordinates 18.39273,-66.14385 as well as the street address Calle 8 Bloque I 32 Dvlas St Cal in , 00959.
For its online presence, you may visit Centro De Patologia Avanzada De Puerto Rico’s website at and engage with its social media outlets through on Twitter and on Facebook.